14-day Premium Trial Subscription Try For FreeTry Free
$11.76
+0.120 (+1.03%)
At Close: May 07, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 DVAX stock ended at $11.76. This is 1.03% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 2.41% from a day low at $11.60 to a day high of $11.88.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Apr 04, 2022 $11.28 $11.67 $11.16 $11.56 1 824 700
Apr 01, 2022 $10.85 $11.25 $10.77 $11.25 1 095 905
Mar 31, 2022 $11.10 $11.64 $10.83 $10.84 980 401
Mar 30, 2022 $11.34 $11.57 $10.94 $11.00 954 792
Mar 29, 2022 $11.20 $11.46 $11.04 $11.37 1 433 600
Mar 28, 2022 $10.94 $11.17 $10.84 $11.03 898 100
Mar 25, 2022 $11.34 $11.34 $10.84 $10.93 983 700
Mar 24, 2022 $11.22 $11.50 $11.20 $11.40 1 627 700
Mar 23, 2022 $11.41 $11.62 $11.12 $11.16 902 100
Mar 22, 2022 $11.54 $11.80 $11.45 $11.56 1 192 253
Mar 21, 2022 $11.76 $11.87 $11.08 $11.41 2 095 206
Mar 18, 2022 $11.34 $11.93 $11.20 $11.81 3 740 704
Mar 17, 2022 $10.87 $11.40 $10.85 $11.32 1 369 900
Mar 16, 2022 $10.65 $10.98 $10.36 $10.97 1 891 100
Mar 15, 2022 $10.35 $10.74 $10.19 $10.44 1 618 300
Mar 14, 2022 $9.87 $10.62 $9.84 $10.25 2 083 400
Mar 11, 2022 $10.29 $10.35 $9.70 $9.75 1 576 900
Mar 10, 2022 $10.22 $10.35 $9.95 $10.19 1 290 900
Mar 09, 2022 $10.37 $10.79 $10.19 $10.40 1 891 800
Mar 08, 2022 $9.86 $10.57 $9.53 $10.05 2 194 100
Mar 07, 2022 $10.18 $10.55 $9.76 $9.87 2 264 600
Mar 04, 2022 $11.12 $11.19 $10.19 $10.46 3 503 500
Mar 03, 2022 $12.55 $12.57 $11.04 $11.28 2 548 000
Mar 02, 2022 $12.37 $12.77 $12.14 $12.58 1 309 900
Mar 01, 2022 $12.15 $13.02 $11.60 $12.21 1 599 700
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT